Drug Price Negotiations

I firmly support lifting the ban on Medicare drug price negotiations and advocate for extending this capability to cover all Americans, including the uninsured. It is unacceptable that in the United States, a country at the forefront of medical innovation, our citizens are forced to pay some of the highest prices in the world for prescription drugs.

Currently, Medicare, which serves millions of our seniors and disabled individuals, is prohibited by law from negotiating drug prices directly with pharmaceutical companies. This policy has long favored the pharmaceutical industry at the expense of our citizens. It’s time for this to change. I believe that by empowering Medicare to negotiate drug prices, we can leverage the purchasing power of the government to secure lower prices, not just for Medicare beneficiaries, but for every American, including those without insurance.

This position isn’t just about reducing costs; it’s about expanding access to essential medications for all, ensuring no one has to choose between filling a prescription and paying for other basic necessities. It’s about fairness, equity, and the basic health security of our people.

I will push for legislation that removes the current barriers to Medicare’s ability to negotiate drug prices. Furthermore, I will work to ensure that these negotiated prices are available to every American, providing immediate relief to millions currently struggling with high drug costs. This policy will not only help in reducing our national healthcare expenditure but also ensure that healthcare in America is a right, not a privilege dictated by economic status.